Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
385 | 3552 | 50.4 | 93% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
227 | 3 | MICRORNA//MIRNA//GENE DELIVERY | 49432 |
476 | 2 | GENE DELIVERY//CELL PENETRATING PEPTIDE//CATIONIC LIPID | 15822 |
385 | 1 | SIRNA//RNA INTERFERENCE//RNAI | 3552 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | SIRNA | authKW | 965794 | 20% | 16% | 723 |
2 | RNA INTERFERENCE | authKW | 938845 | 20% | 15% | 709 |
3 | RNAI | authKW | 617057 | 14% | 15% | 485 |
4 | SMALL INTERFERING RNA | authKW | 293203 | 5% | 19% | 182 |
5 | SHRNA | authKW | 273874 | 5% | 20% | 163 |
6 | GENE SILENCING | authKW | 211167 | 6% | 12% | 202 |
7 | SIRNA DESIGN | authKW | 146112 | 0% | 100% | 17 |
8 | U6 PROMOTER | authKW | 126279 | 1% | 64% | 23 |
9 | SHORT HAIRPIN RNA | authKW | 114123 | 2% | 22% | 61 |
10 | SHORT INTERFERING RNA | authKW | 111508 | 1% | 28% | 46 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biotechnology & Applied Microbiology | 6446 | 19% | 0% | 675 |
2 | Biochemistry & Molecular Biology | 6327 | 37% | 0% | 1309 |
3 | Medicine, Research & Experimental | 4843 | 15% | 0% | 520 |
4 | Virology | 2707 | 7% | 0% | 252 |
5 | Genetics & Heredity | 2553 | 12% | 0% | 438 |
6 | Cell Biology | 1849 | 13% | 0% | 476 |
7 | Pharmacology & Pharmacy | 1406 | 14% | 0% | 494 |
8 | Biophysics | 813 | 7% | 0% | 232 |
9 | Biochemical Research Methods | 762 | 6% | 0% | 206 |
10 | Chemistry, Medicinal | 372 | 4% | 0% | 135 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANTIVIRAL GENE THER Y UNIT | 101327 | 1% | 47% | 25 |
2 | SKIP ACKERMAN MOL THER EUT | 63286 | 0% | 82% | 9 |
3 | GLOBAL RNAI MED | 43176 | 0% | 36% | 14 |
4 | GLOBAL PHARMACEUT ANALYT SCI | 22917 | 0% | 67% | 4 |
5 | GENE FUNCT | 22569 | 1% | 12% | 22 |
6 | CINIMA MED | 19337 | 0% | 75% | 3 |
7 | MED MICROBIOL EXPT VIROL | 17917 | 0% | 17% | 12 |
8 | ANTISENSE CORE | 17190 | 0% | 100% | 2 |
9 | BRAIN KOREA CHEM MAT SCI 21 | 17190 | 0% | 100% | 2 |
10 | FORMULAT S TECHNOL DEV | 17190 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | OLIGONUCLEOTIDES | 64626 | 1% | 17% | 45 |
2 | NUCLEIC ACID THERAPEUTICS | 22828 | 1% | 10% | 26 |
3 | MOLECULAR THERAPY | 20394 | 3% | 3% | 92 |
4 | MOLECULAR THERAPY-NUCLEIC ACIDS | 13734 | 1% | 7% | 22 |
5 | CURRENT OPINION IN MOLECULAR THERAPEUTICS | 8224 | 1% | 3% | 29 |
6 | RNA | 7409 | 1% | 2% | 47 |
7 | NUCLEIC ACIDS RESEARCH | 6498 | 5% | 0% | 176 |
8 | GENE THERAPY | 6314 | 2% | 1% | 54 |
9 | ANTIVIRAL RESEARCH | 4949 | 1% | 1% | 45 |
10 | JOURNAL OF GENE MEDICINE | 4410 | 1% | 2% | 27 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SIRNA | 965794 | 20% | 16% | 723 | Search SIRNA | Search SIRNA |
2 | RNA INTERFERENCE | 938845 | 20% | 15% | 709 | Search RNA+INTERFERENCE | Search RNA+INTERFERENCE |
3 | RNAI | 617057 | 14% | 15% | 485 | Search RNAI | Search RNAI |
4 | SMALL INTERFERING RNA | 293203 | 5% | 19% | 182 | Search SMALL+INTERFERING+RNA | Search SMALL+INTERFERING+RNA |
5 | SHRNA | 273874 | 5% | 20% | 163 | Search SHRNA | Search SHRNA |
6 | GENE SILENCING | 211167 | 6% | 12% | 202 | Search GENE+SILENCING | Search GENE+SILENCING |
7 | SIRNA DESIGN | 146112 | 0% | 100% | 17 | Search SIRNA+DESIGN | Search SIRNA+DESIGN |
8 | U6 PROMOTER | 126279 | 1% | 64% | 23 | Search U6+PROMOTER | Search U6+PROMOTER |
9 | SHORT HAIRPIN RNA | 114123 | 2% | 22% | 61 | Search SHORT+HAIRPIN+RNA | Search SHORT+HAIRPIN+RNA |
10 | SHORT INTERFERING RNA | 111508 | 1% | 28% | 46 | Search SHORT+INTERFERING+RNA | Search SHORT+INTERFERING+RNA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SHUKLA, S , SUMARIA, CS , PRADEEPKUMAR, PI , (2010) EXPLORING CHEMICAL MODIFICATIONS FOR SIRNA THERAPEUTICS: A STRUCTURAL AND FUNCTIONAL OUTLOOK.CHEMMEDCHEM. VOL. 5. ISSUE 3. P. 328 -349 | 151 | 70% | 76 |
2 | KURRECK, J , (2009) RNA INTERFERENCE: FROM BASIC RESEARCH TO THERAPEUTIC APPLICATIONS.ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. VOL. 48. ISSUE 8. P. 1378 -1398 | 116 | 72% | 183 |
3 | RETTIG, GR , BEHLKE, MA , (2012) PROGRESS TOWARD IN VIVO USE OF SIRNAS-II.MOLECULAR THERAPY. VOL. 20. ISSUE 3. P. 483-512 | 152 | 54% | 83 |
4 | WATTS, JK , DELEAVEY, GF , DAMHA, MJ , (2008) CHEMICALLY MODIFIED SIRNA: TOOLS AND APPLICATIONS.DRUG DISCOVERY TODAY. VOL. 13. ISSUE 19-20. P. 842 -855 | 104 | 81% | 183 |
5 | GRINEV, VV , (2012) DESIGN AND QUALITY CONTROL OF SHORT INTERFERING RNA.MOLECULAR BIOLOGY. VOL. 46. ISSUE 6. P. 739-754 | 124 | 78% | 1 |
6 | BEHLKE, MA , (2006) PROGRESS TOWARDS IN VIVO USE OF SIRNAS.MOLECULAR THERAPY. VOL. 13. ISSUE 4. P. 644 -670 | 129 | 57% | 296 |
7 | PEI, Y , TUSCHL, T , (2006) ON THE ART OF IDENTIFYING EFFECTIVE AND SPECIFIC SIRNAS.NATURE METHODS. VOL. 3. ISSUE 9. P. 670-676 | 86 | 93% | 157 |
8 | WHITEHEAD, KA , LANGER, R , ANDERSON, DG , (2009) KNOCKING DOWN BARRIERS: ADVANCES IN SIRNA DELIVERY.NATURE REVIEWS DRUG DISCOVERY. VOL. 8. ISSUE 2. P. 129-138 | 57 | 58% | 1148 |
9 | DE FOUGEROLLES, A , VORNLOCHER, HP , MARAGANORE, J , LIEBERMAN, J , (2007) INTERFERING WITH DISEASE: A PROGRESS REPORT ON SIRNA-BASED THERAPEUTICS.NATURE REVIEWS DRUG DISCOVERY. VOL. 6. ISSUE 6. P. 443 -453 | 69 | 69% | 650 |
10 | BOS, TJ , DE BRUYNE, E , HEIRMAN, C , VANDERKERKEN, K , (2009) IN SEARCH OF THE MOST SUITABLE LENTIVIRAL SHRNA SYSTEM.CURRENT GENE THERAPY. VOL. 9. ISSUE 3. P. 192 -211 | 146 | 59% | 14 |
Classes with closest relation at Level 1 |